Denali Therapeutics Growth Metrics (2017-2026) | DNLI

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Growth Metrics	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Growth Ratios
EBITDA Margin Growth (1y) (Quarter)	0.06M	117.38M	-0.07M	700.26M	0.03M	-5.43M	-0.03M	-0.01M	0.02M	4.81M
EBITDA Margin Growth (3y) (Quarter)	0.29M	0.14M	-0.07M	0.07M	5.83M	-0.74M	0.03M	10.79M	0.11M	116.76M
EBITDA Margin Growth (5y) (Quarter)								0.35M	0.34M	-0.48M
EBITDA Margin (QoQ) (Quarter)	700.24M	-0.12M	0.10M	0.04M	0.01M	-5.58M	5.50M	0.06M	0.04M	-0.78M
EBIT Margin Growth (1y) (Quarter)	0.06M	120.07M	-0.07M	712.18M	0.03M	-5.68M	-0.04M	-0.02M	0.02M	4.94M
EBIT Margin Growth (3y) (Quarter)	0.31M	0.16M	-0.07M	0.09M	6.33M	-0.62M	0.02M	11.50M	0.11M	119.33M
EBIT Margin Growth (5y) (Quarter)								0.37M	0.35M	-0.58M
EBIT Margin (QoQ) (Quarter)	712.16M	-0.12M	0.10M	0.05M	0.00M	-5.83M	5.74M	0.07M	0.04M	-0.90M
EBT Margin Growth (1y) (Quarter)	0.06M	116.18M	-0.07M	700.39M	0.03M	-5.45M	-0.04M	-0.02M	0.02M	4.83M
EBT Margin Growth (3y) (Quarter)	0.29M	0.14M	-0.07M	0.08M	5.91M	-0.78M	0.02M	10.91M	0.11M	115.56M
EBT Margin Growth (5y) (Quarter)								0.37M	0.34M	-0.49M
EBT Margin (QoQ) (Quarter)	700.37M	-0.12M	0.10M	0.04M	0.00M	-5.60M	5.52M	0.07M	0.04M	-0.79M
Enterprise Value Growth (1y) (Quarter)	-138.17%	-8.11%	41.12%	32.24%	18.36%	-6.44%	-54.40%	-34.56%	-11.45%	-0.29%	22.58%	27.29%	24.76%	24.58%	19.54%	12.70%	-0.32%	-1.39%	-4.27%	-20.75%
Enterprise Value Growth (3y) (Quarter)	-52.02%	-40.47%	-23.07%	-25.41%	-30.70%	-32.14%	-47.62%	-29.94%	-29.41%	-4.89%	11.05%	12.80%	11.87%	6.97%	1.29%	5.12%	5.60%	8.47%	13.40%	8.48%
Enterprise Value Growth (5y) (Quarter)				-91.94%	-91.67%	-98.08%	-26.89%	-28.11%	-26.16%	-24.23%	-17.38%	-14.05%	-13.36%	-11.78%	-14.91%	-6.85%	-10.34%	2.47%	10.00%	6.91%
Enterprise Value (QoQ) (Quarter)	7.37%	20.61%	16.72%	-10.64%	-11.61%	-3.50%	-20.81%	3.57%	7.56%	6.86%	6.74%	9.44%	4.36%	6.64%	0.51%	1.73%	-9.91%	5.65%	-2.32%	-13.80%
FCF Margin Growth (1y) (Quarter)	0.04M	3.55M	-0.08M	502.38M	0.03M	-3.35M	-0.00M	-0.00M	0.01M	2.72M
FCF Margin Growth (3y) (Quarter)	0.22M	0.20M	-0.07M	0.06M	5.44M	8.97M		10.63M	0.07M	2.92M
FCF Margin Growth (5y) (Quarter)								-0.53M	0.25M	-0.42M
FCF Margin (QoQ) (Quarter)	502.36M	-0.04M	0.02M	0.04M	0.01M	-3.42M	3.37M	0.04M	0.01M	-0.70M
Net Margin Growth (1y) (Quarter)	0.06M	116.30M	-0.07M	700.39M	0.03M	-5.45M	-0.04M	-0.02M	0.02M	4.83M
Net Margin Growth (3y) (Quarter)	0.29M	0.14M	-0.07M	0.08M	5.88M	-0.80M	0.02M	10.88M	0.11M	115.67M
Net Margin Growth (5y) (Quarter)								0.37M	0.34M	-0.49M
Net Margin (QoQ) (Quarter)	700.37M	-0.12M	0.10M	0.04M	0.00M	-5.60M	5.52M	0.07M	0.04M	-0.79M
Operating Margin Growth (1y) (Quarter)	0.06M	120.07M	-0.07M	712.18M	0.03M	-5.68M	-0.04M	-0.02M	0.02M	4.94M
Operating Margin Growth (3y) (Quarter)	0.31M	0.16M	-0.07M	0.09M	6.33M	-0.62M	0.02M	11.50M	0.11M	119.33M
Operating Margin Growth (5y) (Quarter)								0.37M	0.35M	-0.58M
Operating Margin (QoQ) (Quarter)	712.16M	-0.12M	0.10M	0.05M	0.00M	-5.83M	5.74M	0.07M	0.04M	-0.90M
Return on Assets Growth (1y) (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Assets Growth (3y) (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Assets Growth (5y) (Quarter)								0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	-1.00	0.00M
Return on Assets (QoQ) (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Capital Employed Growth (1y) (Quarter)	0.00M	0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-657.00	-935.00	0.00M	0.00M	0.00M	0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-810.00
Return on Capital Employed Growth (3y) (Quarter)	0.00M	0.00M	-0.00M	-0.00M	-0.00M	-0.00M	525.00	213.00	0.00M	0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-895.00	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M
Return on Capital Employed Growth (5y) (Quarter)								-0.00M	0.00M	0.00M	-947.00	-498.00	-0.00M	-0.00M	287.00	-188.00	-994.00	-0.00M	-0.01M	-0.01M
Return on Capital Employed (QoQ) (Quarter)	6.00	-166.00	-0.00M	-30.00	-182.00	-443.00	-2.00	-308.00	0.00M	-146.00	-348.00	254.00	-0.00M	-247.00	-192.00	-471.00	-546.00	-635.00	-176.00	548.00
Return on Equity Growth (1y) (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Equity Growth (3y) (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Equity Growth (5y) (Quarter)								0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	-1.00	-1.00
Return on Equity (QoQ) (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Invested Capital Growth (1y) (Quarter)	0.00M	0.00M	0.00M		0.00M	0.00M	0.00M		0.00M	0.00M	0.00M
Return on Invested Capital Growth (3y) (Quarter)					0.00M	0.00M			0.00M	0.00M	0.00M
Return on Invested Capital (QoQ) (Quarter)	0.00M	0.00M	0.00M			0.00M	0.00M			0.00M	0.00M
Return on Sales Growth (1y) (Quarter)	6.00	0.01M	-7.00	0.07M	3.00	-545.00	-4.00	-2.00	2.00	483.00	9.00	3.00	-332.00
Return on Sales Growth (3y) (Quarter)	29.00	14.00	-7.00	8.00	588.00	-80.00	2.00	0.00M	11.00	0.01M	-1.00	0.07M	-327.00
Return on Sales Growth (5y) (Quarter)								37.00	34.00	-49.00	-1.00	9.00	258.00
Return on Sales (QoQ) (Quarter)	0.07M	-12.00	10.00	4.00	0.00M	-560.00	552.00	7.00	4.00	-79.00	78.00	0.00M	-331.00

Research Tools

Denali Therapeutics Growth Metrics (2017-2026) | DNLI

Create an account

Sign In

Reset Password